
Thomas Sehested
@tsg_sehested
MD. Interest in cardiology, pharmacoepidemiologi, pharmacoeconomics and prediction. @CopCard
ID: 1131126298447949824
22-05-2019 09:14:59
72 Tweet
194 Followers
348 Following



In this highly relevant case story, Mads Wissenberg LPK Andersen, livid & pialawsonsmith describe a fatal outcome of coronavirus disease 2019 (#COVID19) in a previously healthy 50-year-old man. 🇩🇰article 🇬🇧summary bit.ly/2JzBjrr #Corona #Covid_19 #scd #Coronakrise



Estimated pulse wave velocity predicted CV morbidity and mortality independently of SCORE and FRS in the large multinational MORGAM cohort. Julie Vishram-Nielsen @AllanLinneberg Thomas Sehested Sara Vikström Greve Kari Kuulasmaa ow.ly/FIiS30qy8xu


In this Open Heart sdy S. Kamil Thomas Sehested Gunnar Gislason, H Dominguez et al. found the incidence of #Afli 💓 in pts with #PAD has ⬆️over time, whereas a marked ⬇️ has occurred in the incidence of stroke 🧠🤯 bit.ly/3aUWiAm #openaccess #cardiotwitter #Cardiology


.Mats C. Højbjerg Lassen, MD🌟Kristoffer Grundtvig Skaarup 🌟 TB Sørensen of Copenhagen Cardiovascular Research Center and #CIRL have included almost 2️⃣0️⃣0️⃣ hospitalized 🏨 COVID-19 pts in the #ECHOVID19 sdy. Everybody gets an echo of both heart & lungs 📻 Stay tuned... #cardiotwitter #dkforsk #echofirst #coronavirus #COVID19dk #Covid


AMIOCAT sub-sdy by FJ Olsen, Tor Biering-Sørensen, MD, MSc, MPH, PhD et al: Pts w/ persistent #Afli VS. paroxysmal Afli had: 1) ⬇️LVEF (48 vs. 53%) 2) ⬆️ End-systolic and end-diastolic LA volumes 3) ⬇️ LA emptying fraction (29 vs. 36%) 4) ⬇️ LA strain (20 vs. 26%) 📰bit.ly/2DY7IIC #cardiotwitter




Significant results concerning long-term prognosis for stable event-free patients 1 year after myocardial infarction In the period 2000-2017, 5-year risk: Mortality, 18.6% to 12.5% Recurrent MI, 7.5% to 5.5% Bleeding, 3.9% to 2.7% Copenhagen Cardiovascular Research Center @DanielMolager

Important findings about lifetime risk for simple CHD patients. Nice work by M. El-Chouli. Do we need more follow-up for these patients? Copenhagen Cardiovascular Research Center

Pts w atrial septal defect, ventricular septal defect, pulmonary stenosis, or ductus arteriosus have increased lifetime risk of pulmonary (≈8%), endocrine (≈9%), & neurological disease (≈13%) compared w controls Sdy by M. El-Chouli et al in European Society of Cardiology Journals academic.oup.com/eurheartj/adva…


The lifetime risks of comorbidities and mortality in patients with simple congenital heart disease compared with sex- and birth-year-matched controls! academic.oup.com/eurheartj/adva… #congenital #heart #disease #cardiotwitter #ehj European Society of Cardiology Journals European Society of Cardiology


Addressing comorbidities in simple congenital heart disease: a critical step to achieve optimal long-term outcomes. academic.oup.com/eurheartj/adva… #congenital #CVD #outcome # #cardiotwitter European Society of Cardiology European Society of Cardiology Journals


#ThankYou for 🏷️, dear Cardio-Obstetrics ‼️ 😇 Kudos to Drs Hallum, Basit, Kamper Jørgensen, Thomas Sehested & Boyd who have shown #Women w Hx of #PreEclampsia have high rates of #IHD & #Stroke @ early ages & within a decade after delivery. #CardioObstetrics MIЯVΛƬ #IC prof dr Snezana Rakic


Temporal trends in incidence and prognosis of #myocardialinfarction and risk prediction in #CVD in this PhD-defence by the naturally talented @DanielMolager from @Hjerteforening. What a pleasure to behold! Copenhagen Cardiovascular Research Center #rstats #riskprediction #colliderbias


Ever wonder about all the non-cardiovascular diseases in #MI patients? Read this amazing paper on temporal trends on non-CV disease in MI patients through 17 years by @DanielMolager and Thomas Sehested in JACC Journals. #CardioTwitter #NonCardiotwitter

Pleased to share our latest findings exploring trajectories after MI showing an ⬆️ in the proportion of non-CV causes of death from 24% ➡️ 40% of the 1⃣-year post-MI mortality Should we focus more on non-CV outcomes after MI ❓ @DanielMolager Copenhagen Cardiovascular Research Center Gunnar Gislason M. El-Chouli